Press releaseNewsfile
Envoy Medical
COCH · NASDAQ
$0.6345−$0.0195 (−2.98%)TodayMarket closed ·
Prev close $0.654
Latest news
- Press releaseNewsfile
Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant
- Press releaseNewsfile
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- Press releaseNewsfile
Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th
- Press releaseNewsfile
Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones
- Press releaseNewsfile
Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial
- NewsVandana Singh
EXCLUSIVE: Envoy Medical Hits Key Clinical Trial Milestone for Fully Implanted Ear Implant
- Press releaseNewsfile
Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant
- NewsVandana Singh
EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results
- News
Envoy Medical Submits First Module Of Modular Premarket Approval Application To FDA For Breakthrough Device-Designated Product; Co Plans Four Module Submissions, Final Data Filing Targeted Q2 2027
- Press releaseNewsfile
Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device
- Press releaseNewsfile
Envoy Medical Terminates At-the-Market (ATM) Equity Facility
- Press releaseNewsfile
Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant
- Press releaseNewsfile
Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
- Press releaseNewsfile
Envoy Medical Reports Full Year 2025 Financial Results
- Press releaseNewsfile
Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseNewsfile
Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient
- Press releaseNewsfile
Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial
- Press releaseNewsfile
Envoy Medical Reports Third Quarter 2025 Financial and Operational Results
- Press releaseNewsfile
Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial
- Press releaseGlobe Newswire
Envoy Medical to Present at the Virtual Technology Investor Conference on October 28th
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- NewsAvi Kapoor
Dow Jumps Over 100 Points; US Crude Oil Inventories Increase
- NewsAvi Kapoor
Nasdaq Gains 150 Points; US Mortgage Applications Decline
- NewsAvi Kapoor
Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
- NewsVandana Singh
EXCLUSIVE: Envoy Medical Cuts Capital Needs After FDA Approval For Final Trial Stage Of Cochlear Implant Trial
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Press releaseNewsfile
Envoy Medical to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseNewsfile
Envoy Medical Reports on Second Quarter 2025 Results
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- Press releaseNewsfile
Envoy Medical Reports on First Quarter 2025 Results
- Press releaseNewsfile
Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results
- Press releaseGlobe Newswire
Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- Press releaseGlobe Newswire
Major Envoy Medical Investor Glen Taylor Discusses How Apple's AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company
- Press releaseGlobe Newswire
Envoy Medical Reports Second Quarter 2024 Results and Provides Business Update
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.